UCL Queen Square Institute of Neurology


Professor Lisa Cipolotti elected to Academy of Medical Sciences

12 May 2021

We are delighted to announce that Professor Cipolotti (UCL Queen Square Institute of Neurology) has been elected Fellow of the Academy of Medical Sciences in recognition of her exceptional contributions to biomedical and health science.

Professor Cipolotti

Professor Lisa Cipolotti is among 50 scientists and scholars to be elected to the prestigious fellowship this year. 


They have been selected for their innovative research discoveries and for translating scientific developments into benefits for patients and the wider society.

Professor Cipolotti’s research focuses on how neurological conditions affect cognitive abilities, in order to develop accurate diagnoses of impairments arising from brain disease or injury. In addition to her role as Professor of Neuropsychology at UCL, she has been head of the neuropsychology department at the National Hospital for Neurology and Neurosurgery since 1995.

Commenting on UCL’s five new AMS Fellows, Professor David Lomas, UCL Vice Provost (Health), said: “Each of the new fellows from UCL has made an outstanding contribution to biomedical science and their work has helped to improve lives by tackling some enormous health challenges.

“The diverse range of work recognised, ranging from nanotechnology to hypertension to healthcare law, reflects the vast strengths in health research, education and enterprise that UCL encompasses and nurtures.

“Congratulations to all on this fabulous accolade.”

Professor Dame Anne Johnson, Co-Director of UCL Health of the Public and President of the Academy of Medical Sciences, said: “I am truly delighted to welcome these 50 new Fellows to the Academy’s Fellowship, and I offer my congratulations to each of them on their exceptional contribution to biomedical and health science. The knowledge, skill and influence that each brings to the Fellowship is the Academy’s most powerful asset.

“I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration. I am pleased that the newest cohort of Fellows demonstrates this breadth of expertise, from microbiology to healthcare law and medical statistics.”

The new Fellows will be formally admitted to the Academy on 1 July.